Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
*Elettaria cardamomum* extract, commonly known as cardamom extract, is a botanical substance derived from the seeds of the green cardamom plant. It is characterized by its rich content of bioactive compounds, including 1,8-cineole and alpha-terpinyl acetate, which confer antioxidant and anti-inflammatory properties. In therapeutic research, the extract is investigated for its neuroprotective effects, particularly its ability to reduce neuroinflammation by lowering levels of pro-inflammatory cytokines such as Tumor Necrosis Factor alpha (TNF-α) in the hippocampus. Preclinical studies suggest that when used as an adjunct to anti-obesity treatments like orlistat, it may help mitigate cognitive impairments and memory dysfunction associated with high-fat diets and obesity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on elettaria cardamomum extract.